Monostotic fibrous dysplasia is a medical condition that can be defined as a benign bone disorder primarily affecting a single bone. It is characterized by the abnormal development and growth of fibrous tissue within the affected bone, leading to a weakening of its structure. This condition most commonly occurs during childhood or adolescence.
The term "monostotic" indicates the involvement of only one bone in the body, whereas "fibrous dysplasia" refers to the presence of abnormal fibrous tissue. The abnormal tissue growth can cause the affected bone to become weaker, more brittle, and prone to fractures or deformities.
Symptoms of monostotic fibrous dysplasia may vary depending on the location and severity of the condition but can include pain, swelling, or tenderness in the affected bone. In some cases, there may be noticeable deformities such as a visible lump or uneven growth.
The exact cause of monostotic fibrous dysplasia is not fully understood, although it is believed to be related to genetic mutations that occur during fetal development. This condition is not inherited and is considered a sporadic or random occurrence.
Treatment options for monostotic fibrous dysplasia are often aimed at managing symptoms, preventing fractures, and addressing any deformities that may be present. These can include pain management, physical therapy, supportive devices (such as braces or splints), or surgery in more severe cases. Regular monitoring and follow-up appointments are typically recommended to assess and manage the condition appropriately.
